HealthMore in Health→
Prime Medicine Revives Shelved Gene Therapy After FDA Shift
Key Takeaways
- Prime Medicine revives previously shelved rare immune disease therapy
- FDA's evolving stance on rare disease approvals drove the reversal
- Prime editing offers more precise gene correction than traditional CRISPR
DE
DT Editorial Team··4 min read·via endpoints.news